Bearish flow noted in Neumora Therapeutics (NMRA) Inc with 6,521 puts trading, or 9x expected. Most active are Jan-25 5 puts and Jan-25 7.5 puts, with total volume in those strikes near 5,900 contracts. The Put/Call Ratio is 6.25, while ATM IV is up nearly 29 points on the day. Earnings are expected on March 6th.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMRA:
- Neumora Therapeutics Inc put volume heavy and directionally bearish
- J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital
- Neumora Therapeutics Reports Q3 2024 Financial Results
- Neumora Therapeutics reports Q3 EPS (45c), consensus (39c)
- Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan